NASDAQ: NKTR

Nektar Therapeutics

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nektar Therapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 5, 2026.

If you purchased Nektar securities and would like to join the action, please click “Join This Class Action.”

Class Period:February 26, 2025 through December 15, 2025

Deadline:

16 Days
If you purchased Nektar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Contact Us

Details of the case:

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that:

  • enrollment in the REZOLVE-AA trial had not followed applicable instructions and protocol standards;
  • the foregoing was likely to have a significant negative impact on the REZOLVE-AA trial’s results;
  • accordingly, the REZOLVE-AA trial’s overall integrity and prospects were overstated; and
  • as a result, defendants’ public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: Nektar Therapeutics
Stock Symbol: NKTR
Class Period: February 26, 2025 through December 15, 2025
Court: United States District Court District of the Northern District of California

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Rosenlegal
Scroll to Top